NL-OMON51484招募中不适用
Biomarker identification of radionuclide therapy-induced radiation responses. - Radio-Marker
Moleculaire genetica0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patient with an advanced of metastatic, well-differentiated
- •gastroenteropancreatic neuroendocrine tumor .
- •- Indication for treatment with PRRT with 7.4 GBq 177Lu-DOTATATE by the
- •multidisciplinary team.
- •- Age >= 18 years.
排除标准
- •- Failure to obtain informed concent.
- •- Patient received ionizing radiation for imaging purposes within one week
- •prior to PRRT or ionizing radiation for therapeutic purposes within 3 months
- •prior to PRRT.
- •- Previous treatment with PRRT.
- •- Indication to receive a lower activity of PRRT than 7.4 GBq.
研究者
相似试验
未知
不适用
Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostainingEsophageal cancerJPRN-UMIN000025542Tohoku University90
招募中
不适用
Biomarker associated with the radiation therapy of renal cell cancer.C64Malignant neoplasm of kidney, except renal pelvisDRKS00010924niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde10
暂停
Unknown
Radiobiological characterisation and therapy monitoring of oligo- compared to polymetastatic breast cancerC50Malignant neoplasm of breastDRKS00031591Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf50
Unknown
不适用
Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid TumorsRadiation ToxicityAdvanced CancerRadiosensitivityNCT04110223Shandong Cancer Hospital and Institute600
招募中
不适用
Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STSSoft Tissue SarcomasNCT05739084Centre Leon Berard300